Immunome Newsroom

Immunome (IMNM) Receives a Buy From J.P. Morgan

TipRanksNov 19 07:13 ET

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsNov 14 09:33 ET

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Moomoo NewsNov 14 08:33 ET

Immunome Is Maintained at Overweight by Piper Sandler

Dow JonesNov 14 07:36 ET

Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsNov 14 07:31 ET

Immunome Analyst Ratings

BenzingaNov 14 07:26 ET

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Moomoo NewsNov 13 20:32 ET

Promising Growth Potential for Immunome: Buy Rating Backed by Strategic Acquisitions and Innovative Pipeline

TipRanksNov 13 20:17 ET

Stephens Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $30

Moomoo NewsNov 7 17:32 ET

Immunome Initiated With an Overweight at Stephens on 'Seasoned Leadership'

TipRanksNov 7 16:45 ET

Immunome Analyst Ratings

BenzingaOct 25 11:07 ET

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsOct 25 08:31 ET

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Moomoo NewsSep 16 08:31 ET

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsAug 14 08:34 ET

Leerink Partners Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsAug 13 10:32 ET

Buy Rating Affirmed on Immunome: Promising Clinical Trials and Strategic Growth Prospects

TipRanksAug 13 10:23 ET

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Moomoo NewsAug 13 07:31 ET

Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Cuts Target Price to $23

Moomoo NewsAug 13 07:31 ET

Immunome Analyst Ratings

BenzingaAug 13 07:25 ET

Piper Sandler Sticks to Their Buy Rating for Immunome (IMNM)

TipRanksAug 13 06:57 ET